Patent · US Active

Amino-substituted 8-N-benzimidazoles and methods for their use in blood sugar disorders

US8003668B2 · kind B2 · utility

4Cited by

0References

2Claims

0Family size

Assignee

Sanofi-Aventis · FR

Inventors

Elisabeth Defossa · Idstein, DE
Karl Schoenafinger · Alzenau, DE
Gerhard Jaehne · Frankfurt, DE
Christian Buning · Frankfurt am Main, DE
Georg Tschank · Frankfurt am Main, DE
Ulrich Werner · Frankfurt am Main, DE

Key dates

Filing date	Sep 14, 2007
Grant date	Aug 23, 2011
Priority date	—
Expiry date	Apr 8, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention comprises the use of amino-substituted 8-N-benzimidazoles compounds of formula Iwherein R3, R4-R5, R11 and R20-R21 are hereinafter defined which display a therapeutically utilizable blood sugar-lowering action. These compounds are intended to be particularly suitable in the treatment of diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.